Article
Controversy on the Management of Patients Carrying RET p.V804M Mutation
2021-08-17
Abstract excerpt
<title>Abstract</title> <p><bold>Context:</bold><italic> RET</italic> p.V804M is classified as a moderate-risk mutation for familial medullary thyroid cancer (FMTC). There is a significant controversy on the management of patients carrying this mutation. We describe a family incidentally discovered to have this mutation during evaluation of a newborn with dysmorphic features. We provide a comprehensive literature...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 579fc2a2-e1ba-514e-9093-43375cbec00d
- DOI
- 10.21203/rs.3.rs-799440/v1
